25th -26th Febuary 2021

3rd Edition MarketsandMarkets Next Gen Microbiome and Probiotics- Virtual Conference (Time Zone- Eastern Standard Time (EST))

Witness the significant development of microbiome, probiotics and prebiotics research alongside their applications relating to difficulties like therapeutic information understanding, speculation and administrative obstacles looked by the experts. The convergence between developing innovation and disclosure with the setting of consumer intrigue. Recognize the non-distinguished dysbiosis, to find the expected territories under examination for interests in Gut and Skin microbiome and its part as an indicative instrument of drug revelation. 

Connect with biotech, pharma, academicians and investors at 3rd Edition Next Gen Microbiome and Probiotics- Virtual Conference, February 2021 discussing the most ingenious research and technological advances. This online conference will hold discussions on the nutraceutical and consumer approaches along with Microbiome as a science and its clinical application. Key sessions on R& D to commercialization- how to effectively translate research into commercialization along with overcoming microbiome research and probiotics product development challenges.

WHAT TO EXPECT
Key Highlights
  • Microbial Innovations
  • Gut and Skin Microbiota
  • Regulatory Issues
  • Pediatrics and infant health
  • Live Probiotic Technology
  • Strain Identification
  • Fecal Microbiota & Engineered Microbiome
  • Commercialization and R&D Collaborations
     
Who Should Attend?

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

  • Microbiome discovery
  • Department of Biochemistry and Immunology
  • Microbiome science
  • Microbiology
  • Biological Science
  • Gut Biology
  • Human microbiome
  • Drug discovery
  • Therapeutics
  • Immunotherapy 
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Naveen Jain

Naveen Jain

Founder & CEO
Viome

Naveen Jain

Founder & CEO
Viome
 Julius Goepp

Julius Goepp

Founder, CEO
Scaled Microbiomics

Julius Goepp

Founder, CEO
Scaled Microbiomics
Petronille Houdart

Petronille Houdart

Skincare Director
Sequential Skin

Petronille Houdart

Skincare Director
Sequential Skin
Linda Krebs

Linda Krebs

Cofounder, COO
Bebe and Bella

Linda Krebs

Cofounder, COO
Bebe and Bella
 Allison Krebs-Bensch

Allison Krebs-Bensch

CEO
US Pharmaceutical Corporation

Allison Krebs-Bensch

CEO
US Pharmaceutical Corporation
Yug Varma

Yug Varma

CEO
Phi Therapeutics

Yug Varma

CEO
Phi Therapeutics
 David Kyle

David Kyle

Executive Chairman and CSO
Evolve Biosystems

David Kyle

Executive Chairman and CSO
Evolve Biosystems
 Julie Schwedock

Julie Schwedock

Associate Director, Microbial Development Team
Takeda Pharmaceuticals

Julie Schwedock

Associate Director, Microbial Development Team
Takeda Pharmaceuticals
PAST EVENT GALLERY